Le Lézard
Classified in: Health
Subjects: LEG, POL, STP, AVO

Physician to Testify Before New York Legislature on Assisted Suicide


NEW YORK, May 3, 2018 /PRNewswire/ -- T. Brian Callister, M.D. of Reno, Nevada, will testify this morning before a New York State Assembly health committee in New York City regarding his opposition to physician-assisted suicide and euthanasia. Callister is an internationally recognized expert on care transitions and end-of-life care. He has practiced medicine for 30 years and is currently an associate professor of medicine at the University of Nevada, Reno School of Medicine.

"I look forward to sharing my experiences which have resulted in my passionate opposition to physician-assisted suicide with the New York Assembly members," Callister said. "There is a growing ground-swell of insurance companies who believe that physician-assisted suicide is better for patients without consideration of the quality of life, because for them, it's the least-expensive option."

Callister said he has seen this first hand when two different patients were denied potentially life-saving procedures, with the insurance companies suggesting that physician-assisted suicide might be a better solution.

The New York State Assembly is currently holding hearings regarding a legislative bill (A.2383-A --Paulin) to pass a state law in favor of physician-assisted suicide. The Assembly began hearings on the bill in Albany during April and continues through today in Manhattan.

About Dr. Callister

T. Brian Callister, M.D., FACP, SFHM, is a Board Certified Internal Medicine and Hospitalist physician and associate professor of medicine at the University of Nevada, Reno School of Medicine. He is internationally recognized as an outspoken critic of assisted suicide and euthanasia and a frequent contributor to legislative bodies and the media on this topic. Dr. Callister is the governor-elect of Nevada for the American College of Physicians and was nominated by Modern Healthcare as one of the 50 Most Influential Physician Executives in Healthcare. He is a Fellow of the American College of Physicians and a Senior Fellow of the Society of Hospital Medicine.

Callister's medical career has spanned four decades and he is a well-known speaker in the healthcare arena. He received his M.D. from the University of Utah School of Medicine where he graduated Alpha Omega Alpha. He graduated Phi Beta Kappa from Stanford University with a bachelor's degree in economics.

Dr. Callister Photo: https://bit.ly/2jpri2S

Dr. Callister CV: https://bit.ly/2FCIz1c

Media Contact:

Ira M. Gostin, MBA
120 West Strategic Communications
[email protected]
775-525-9371

SOURCE T. Brian Callister, M.D.


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: